At 6 months follow-up it is questioned what the baseline complaint was and if they are recovered.
All complaints listed by patients in their baseline questionnaire were transferred to their follow-up questionnaires by the study office personnel, which ensured that each baseline complaint was assessed at each subsequent follow-up.
Baseline sleep complaints did not adversely affect clinical outcome at one-year follow-up: severity of the sleep complaints at baseline was associated with a steeper improvement of depressive and anxiety symptoms, suicidality/self-harm symptoms, and overall psychosocial functioning over time.
Contrary to our expectations, however, baseline sleep complaints did not adversely affect clinical outcome at one-year follow-up.
Severity of baseline sleep complaints did not have an unfavorable effect on clinical outcome in a one-year naturalistic clinical follow-up, suggesting that sleep disturbances at baseline do not necessarily lead to poorer clinical outcome during follow-up.
The use of antidepressants, use of anxiolytics, use of antipsychotics, use of nonbenzodiazepine sleep medication (z-drugs), the amount of treatment appointments (cutoff ≥10 treatment appointments) during the 1-year follow-up period, or the amount of comorbid psychiatric disorders was not associated with the baseline sleep complaint severity score (independent samples t-tests n.s).s
If P d) becomes too large, then the observed complaint levels are significantly greater than the baseline predictions and complaint levels are deemed anomalously high.
The PGI registers the patient's own health complaints at baseline and the severity of these at baseline and follow-up points (the PGI-open format) [ 37].
Having many sleep complaints at baseline, although linked with a less favourable baseline status, was associated with a significantly quicker improvement of depression and anxiety symptoms and overall psychosocial functioning over time.
Females reported significantly more somatic complaints at baseline than males.
